missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human TACE/ADAM17 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity
Marca: R&D Systems™ 930-ADB-010
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The Recombinant Human TACE/ADAM17 Protein is derived from Sf 21 (baculovirus). The Recombinant Human TACE/ADAM17 Protein has been validated for the following applications: Enzyme Activity.Especificaciones
| Lyophilized from a 0.2μm filtered solution in Tris, NaCl and Brij-35. | |
| 52 kDa | |
| 10 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 6868 | |
| TACE/ADAM17 | |
| Spodoptera frugiperda,Sf 21 (baculovirus)-derived human TACE/ADAM17 protein Arg215-Asn671,with a C-terminal 6-His tag | |
| Mature form. Recombinant Human TACE/ADAM17 is prone to proteolytic cleavage at C-terminus. The predominant form of the purified protein lacks the His tag. | |
| Recombinant |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido